DMRA
Damora TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
DMRA vs peer average
70/100
DMRA vs. peer average (C vs. D)
Grade spread
C 1 · D 6 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CING is the first available peer comparator.
Cingulate fits mainly as a micro-cap development-stage volatility benchmark with dependence on execution milestones and capital markets access.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
DMRA
Damora Therapeutics
CING
Cingulate
Grade
C
C
Momentum
16
26
Value
41
41
Sentiment
75
76
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs CING
DMRA / CING
Grade Position
Above peers
DMRA vs. peer average (C vs. D)
70/100
Momentum
16
CINGValue
41
DMRASentiment
75
CINGRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs DMRA
CING is the first peer returned for this comparison set.